Autoreactive Trms in vitiligo require IL-15 for their maintenance in the epidermis, and studies in mice revealed that blockade of IL-15 signaling removed the Trms from the skin, resulting in repigmentation even after a short course of treatment. The gene discussed is IL15; the disease is vitiligo.